Abstract Peroxisome proliferator activated receptor γ coactivator-1 alpha (PGC-1α) is a transcriptional coactivator that influences various energy metabolism processes and plays a crucial role in fat deposition. To investigate the function and underlying mechanisms of the PGC-1α gene in lipid metabolism, a series of experiments were performed. The expression of PGC-1α in 12 different tissues was examined in chickens (Gallus gallus). Using RT-PCR, the CDS of the chicken PGC-1α gene was amplified and obtained, and a eukaryotic expression vector was constructed. The vector was then transfected into the leghorn male hepatoma (LMH) cell line, and Western blot analysis was used to confirm the expression of the PGC-1α protein. After overexpressing and knocking down PGC-1α gene in LMH cells, lipid droplet deposition was assessed using oil red O staining, total triglyceride (TG) content was measured by colorimetric assay, and the expression of lipid metabolism-related genes was analyzed through qPCR. The results showed that PGC-1α had the highest expression in cardiac tissue, with relatively high levels in leg muscle, kidney, and brain tissues. Western blot analysis confirmed that the overexpression vector successfully expressed the fusion protein in LMH cells. Overexpression of PGC-1α led to a extremely significant reduction in lipid deposition and TG content (P<0.01), while knockdown of PGC-1α resulted in a trend of increased lipid deposition and a significant rise in TG content (P<0.05). Moreover, overexpression of PGC-1α significantly downregulated the expression of fatty acid synthetase (FASN), peroxisome proliferator activated receptor γ (PPARγ) and acetyl-CoA carboxylase alpha (ACACA) genes (P<0.05 or P<0.01), while extremely significantly upregulated phosphoenolpyruvate carboxykinase 1 (PCK1) (P<0.01). Knockdown of PGC-1α extremely significantly decreased PCK1 expression (P<0.01). These findings suggested that the chicken PGC-1α gene likely exerts its effects by regulating the expression of these functional genes. By constructing overexpression and knockdown models of the PGC-1α gene, this study reveals its key regulatory role in chicken lipid metabolism, particularly through modulating the expression of FASN, PPARγ, ACACA, and PCK1, which affect lipid deposition and triglyceride levels. This study provides a valuable reference for further exploration of the functional mechanisms of PGC-1α in chicken lipid metabolism.
ZHOU Bo,WEI Zhi-Heng,LIU Shi-Hao, et al. Construction of Eukaryotic Expression Vector for Chicken (Gallus gallus) PGC-1α Gene and Its Effect on Lipid Metabolism[J]. 农业生物技术学报, 2025, 33(2): 344-354.
[1] 刘世昊, 魏志恒, 姜新城, 等. 2024. 鸡THRSP基因对LMH细胞脂质沉积的调控作用[J]. 农业生物技术学报, 32(7): 1596~1605.
(Liu S H, Wei Z H, Jiang X C, et al.2024. Regulatory effect of chicken (Gallus gallus) THRSP gene on lipid deposition in LMH cells[J]. Journal of Agricultural Biotechnology, 32(7): 1596~1605.)
[2] 牛尚梅. 2015. 骨骼肌PGC-1α在高脂导致的胰岛素抵抗中的作用机制[D]. 硕士学位论文, 河北医科大学, pp.13-14.
(Niu S M.2015. The molecular mechanism of skeletal muscle PGC-1α on insulin resistance induced by high fat diet in rat[D]. Thesis for M. D., Hebei Medical University, pp. 13-14.)
[3] 单艳菊, 束婧婷, 章明, 等. 2016. PGC-1α基因在两个品种鸡两种表型肌肉中的差异表达[J]. 农业生物技术学报, 24(12): 1900~1907.
(Shan Y J, Shu J T, Zhang M, et al.2016. Differential expression profile of PGC-1α gene in two phenotypically distinct muscles between two chicken (Gallus gallus) breeds[J]. Journal of Agricultural Biotechnology, 24(12): 1900~1907.)
[4] 束婧婷, 宋卫涛, 朱文奇, 等.2013. PGC-1α基因在两种类型鸡骨骼肌间的表达差异[J].江苏农业学报, 29(1): 121-125.
(Shu J T, Song W T, Zhu W Q, et al.2013. Differentiation of PGC-1α gene expression in skeletal muscles of two chicken breeds[J]. Jiangsu Journal of Agricultural Science, 29(1): 121~125.)
[5] 王慧婷, 张岩晨, 徐梦怡, 等. 2020. 能量代谢关键调控因子PGC-1α的研究进展[J]. 生理学报, 72(6): 804-816.
(Wang H T, Zhang Y C, Xu M Y, et al.2020. Research progresses on PGC-1α, a key energy metabolic regulator[J]. Acta Physiologica Sinica, 72(6): 804-816.)
[6] 赵云丽, 袁勇, 马晓莉, 等. 2021. 基于AMPK/SIRT1/PGC-1α信号通路研究香青兰总黄酮对大鼠心肌缺血再灌注损伤的保护机制[J]. 中国药房, 32(3): 278~283.
(Zhao Y L, Yuan Y, Ma X L, et al.2021. Study on protective mechanism of dracocephalum moldavica total flavonoids against myocardial ischemia reperfusion injury in rats based on AMPK/SIRT1/PGC-1α signaling pathway[J]. China Pharmacy, 32(3): 278~283.)
[7] Banerji R, Huynh C, Figueroa F, et al.2021. Enhancing glucose metabolism via gluconeogenesis is therapeutic in a zebrafish model of Dravet syndrome[J]. Brain Communications, 3(1): fcab004.
[8] Burgess S C, Leone T C, Wende A R, et al.2006. Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-la (PGC-1a)-deficient mice[J]. Journal of Biological Chemistry, 281(28): 19000-19008.
[9] Chen H, Fan W, He H, et al.2022. PGC-1: A key regulator in bone homeostasis[J]. Journal of Bone and Mineral Metabolism, 40(1): 1-8.
[10] Feng Y, Zhang Y, Xiao H.2018. AMPK and cardiac remodelling[J]. Science China (Life Sciences), 61(1): 14-23.
[11] He S, Liang X F, Qu C M, et al.2012. Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella)[J]. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 155(2): 381-388.
[12] Herzig S, Long F X, Jhala U S, et al.2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1[J]. Nature, 413(6852): 179-183.
[13] Hu Y, Zhang Y, Liu C, et al.2020. Multi-omics profiling highlights lipid metabolism alterations in pigs fed low-dose antibiotics[J]. BMC Genetics, 21(1): 112.
[14] Kalemba K M, Wang Y, Xu H, et al.2019. Glycerol induces G6pc in primary mouse hepatocytes and is the preferred substrate for gluconeogenesis both in vitro and in vivo[J]. Journal of Biological Chemistry, 294(48): 18017-18028.
[15] Kong S, Cai B, Nie Q.2022. PGC-1α affects skeletal muscle and adipose tissue development by regulating mitochondrial biogenesis[J]. Molecular Genetics and Genomics, 297(3): 621-633.
[16] Lehman J J, Barger P M, Kovacs A, et al.2000. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis[J]. The Journal of Clinical Investigation, 106: 847-856.
[17] Leone T C, Lehman J J, Finck B N, et al.2005. PGC-1alpha deficiency causes multi-system energy metabolic derangements: Muscle dysfunction, abnormal weight control and hepatic steatosis[J]. PLOS Biology, 3(4): E101.
[18] Léveillé M, Besse-Patin A, Jouvet N, et al.2020. PGC-1α isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments[J]. Molecular Metabolism, 34: 72-84.
[19] Martínez-RedondoV, Pettersson A T, Ruas J L.2015. The hitchhiker's guide to PGC-1α isoform structure and biological functions[J]. Diabetologia, 58(9): 1969-1977.
[20] Oka S, Sabry A D, Cawley K M, et al.2020. Multiple levels of PGC-1α dysregulation in heart failure[J]. Frontiers in Cardiovascular Medicine, 7: 2.
[21] Puigserver P, Spiegelman B M.2003. Peroxisome proliferator-activated receptor-γ coactivator 1 (PGC-1a): Transcriptional coactivator and metabolic regulator[J]. Endocrine Reviews. 24(1): 78-90.
[22] Qian L, Zhu Y, Deng C, et al.2024. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases[J]. Signal Transduction and Targeted Therapy, 9(1): 50 (1-44).
[23] Rius-Pérez S, Torres-Cuevas I, Millán I, et al.2020. PGC-1α, inflammation, and oxidative stress: An integrative view in metabolism[J]. Oxidative Medicine and Cellular Longevity, 2020: 1452696.
[24] Schreiber S N, Emter R, Hock M B, et al.2004. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis[J]. Proceedings of the National Academy of Sciences of the USA, 101(17): 6472-6477.
[25] Vega R B, Huss J M, Kelly D P.2000. The coactivator PGC-1 cooperates with peroxisome proliferator activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes[J]. Molecular Cellular Biology, 20(5): 1868-1876.
[26] Wu G Q, Deng X M, Li J Y, et al.2006. A potential molecular marker for selection against abdominal fatness in chickens[J]. Poultry Science, 85(11): 1896-1899
[27] Xu D, Wang Z, Xia Y, et al.2020. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis[J]. Nature, 580(7804): 530-535.
[28] Yang J, Kalhan S C, Hanson R W.2009. What is the metabolic role of phosphoenolpyruvate carboxykinase?[J]. Journal of Biological Chemistry, 284(40): 27025-27029.
[29] Yoon J C, Puigserver P, Chen G X, et al.2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1[J]. Nature, 413(6852): 131-138.
[30] Yu S, Meng S, Xiang M, et al.2021. Phosphoenolpyruvate carboxykinase in cell metabolism: roles and mechanisms beyond gluconeogenesis[J]. Molecular Metabolism, 53: 101257.
[31] Zhang H, Liu S, Cai Z, et al.2021. Down-regulation of ACACA suppresses the malignant progression of prostate cancer through inhibiting mitochondrial potential[J]. Journal of Cancer, 12(1): 232-243.
